Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lauer

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
Journal of Pediatric Hematology/Oncology|March 3, 2011
Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology GroupWanda L Salzer, Naomi J Winick, Pierre Wacker, et al.
Journal of Pediatric Psychology|October 23, 1998
Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxisR T Brown, A Madan-Swain, G A Walco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemiaD I Marks, B W Kurz, M P Link, et al.
The Lancet. Oncology|June 1, 2005
Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosisAndrew L Feldman, Frank Berthold, Robert J Arceci, et al.
Journal of Pediatric Hematology/Oncology|June 17, 1998
Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot StudyS J Lauer, B M Camitta, B G Leventhal, et al.
International Journal of Molecular Sciences|July 28, 2022
Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of PatientsJonas Feldheim, David Wend, Mara J Lauer, et al.
Leukemia|July 18, 2001
A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trialS J Lauer, J J Shuster, D H Mahoney, et al.
Cancer|May 15, 1995
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot studyD H Mahoney, B M Camitta, B G Leventhal, et al.
Cancer|November 15, 1987
Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemiaS J Lauer, D Pinkel, G R Buchanan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1984
Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiationL E Kun, B M Camitta, R K Mulhern, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Journal of Pediatric Hematology/Oncology|March 3, 2011
Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology GroupWanda L Salzer, Naomi J Winick, Pierre Wacker, et al.
Journal of Pediatric Psychology|October 23, 1998
Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxisR T Brown, A Madan-Swain, G A Walco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemiaD I Marks, B W Kurz, M P Link, et al.
The Lancet. Oncology|June 1, 2005
Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosisAndrew L Feldman, Frank Berthold, Robert J Arceci, et al.
Journal of Pediatric Hematology/Oncology|June 17, 1998
Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot StudyS J Lauer, B M Camitta, B G Leventhal, et al.
International Journal of Molecular Sciences|July 28, 2022
Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of PatientsJonas Feldheim, David Wend, Mara J Lauer, et al.
Leukemia|July 18, 2001
A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trialS J Lauer, J J Shuster, D H Mahoney, et al.
Cancer|May 15, 1995
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot studyD H Mahoney, B M Camitta, B G Leventhal, et al.
Cancer|November 15, 1987
Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemiaS J Lauer, D Pinkel, G R Buchanan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1984
Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiationL E Kun, B M Camitta, R K Mulhern, et al.
Pageof 19